Ana Sebio

1.5k total citations
67 papers, 980 citations indexed

About

Ana Sebio is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ana Sebio has authored 67 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 21 papers in Molecular Biology. Recurrent topics in Ana Sebio's work include Sarcoma Diagnosis and Treatment (22 papers), Colorectal Cancer Treatments and Studies (19 papers) and Genetic factors in colorectal cancer (11 papers). Ana Sebio is often cited by papers focused on Sarcoma Diagnosis and Treatment (22 papers), Colorectal Cancer Treatments and Studies (19 papers) and Genetic factors in colorectal cancer (11 papers). Ana Sebio collaborates with scholars based in Spain, United States and Japan. Ana Sebio's co-authors include Heinz‐Josef Lenz, Michaël Kahn, David Páez, Juliana Salazar, Agustí Barnadas, Montserrat Baiget, Laia Paré, Sebastian Stintzing, Stefan Stremitzer and E. del Rı́o and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Ana Sebio

62 papers receiving 972 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Sebio Spain 15 542 512 214 177 123 67 980
Xuenong Ouyang China 16 484 0.9× 395 0.8× 239 1.1× 211 1.2× 80 0.7× 53 894
Qiang Zuo China 13 417 0.8× 315 0.6× 133 0.6× 200 1.1× 100 0.8× 39 805
Xuequan Yao China 20 494 0.9× 313 0.6× 172 0.8× 305 1.7× 55 0.4× 37 921
Yufei Jiao Japan 18 373 0.7× 264 0.5× 151 0.7× 223 1.3× 223 1.8× 38 847
Shu Zhao China 21 490 0.9× 785 1.5× 337 1.6× 409 2.3× 134 1.1× 43 1.4k
Neyaz Alam India 21 962 1.8× 362 0.7× 387 1.8× 381 2.2× 154 1.3× 56 1.4k
Jun Liang China 19 585 1.1× 201 0.4× 117 0.5× 406 2.3× 104 0.8× 49 927
Sachin Gopalkrishna Pai United States 17 578 1.1× 466 0.9× 296 1.4× 325 1.8× 126 1.0× 32 1.2k
Akihiko Miyanaga Japan 18 638 1.2× 446 0.9× 426 2.0× 295 1.7× 83 0.7× 75 1.1k
Song He China 19 615 1.1× 321 0.6× 122 0.6× 208 1.2× 102 0.8× 49 1.0k

Countries citing papers authored by Ana Sebio

Since Specialization
Citations

This map shows the geographic impact of Ana Sebio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Sebio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Sebio more than expected).

Fields of papers citing papers by Ana Sebio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Sebio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Sebio. The network helps show where Ana Sebio may publish in the future.

Co-authorship network of co-authors of Ana Sebio

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Sebio. A scholar is included among the top collaborators of Ana Sebio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Sebio. Ana Sebio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Majerčáková, Katarina, et al.. (2025). Role of Spatially Fractionated Radiotherapy (LATTICE) Treatment in Inoperable Bulky Soft-Tissue Sarcomas. Cancers. 17(4). 624–624. 2 indexed citations
2.
Palmerini, Emanuela, Antonio López–Pousa, Giovanni Grignani, et al.. (2024). Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single‐arm, phase 2 trial. Cancer. 131(1). e35628–e35628. 6 indexed citations
3.
Muñoz‐Casares, Francisco Cristobal, Javier Martín‐Broto, Pedro Antonio Cáscales-Campos, et al.. (2024). Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations. Cancers. 16(15). 2646–2646. 1 indexed citations
4.
Martín‐Broto, Javier, Robert Díaz Beveridge, David S. Moura, et al.. (2024). Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS). Journal of Clinical Oncology. 43(3). 297–307. 11 indexed citations
5.
Salazar, Juliana, María J. Arranz, Javier Martín‐Broto, et al.. (2024). Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol. Pharmaceutics. 16(12). 1585–1585. 1 indexed citations
6.
Manrique, A.C. Virgili, Juliana Salazar, Alberto Gallardo, et al.. (2024). CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics. 14(11). 1195–1195.
7.
Sebio, Ana, J. Orcajo Rincón, Javier Martín‐Broto, et al.. (2024). Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS). Clinical & Translational Oncology. 27(3). 824–836.
8.
9.
Serrano, César, Rosa Álvarez, Juan Antonio Carrasco, et al.. (2023). SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022). Clinical & Translational Oncology. 25(9). 2707–2717. 3 indexed citations
10.
Moura, David S., Juan Díaz‐Martín, Sílvia Bagué, et al.. (2021). A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report. International Journal of Molecular Sciences. 22(14). 7514–7514. 5 indexed citations
11.
Wu, Anna H., Shu Cao, Diana L. Hanna, et al.. (2017). Prognostic impact of FOXF1 polymorphisms in gastric cancer patients. The Pharmacogenomics Journal. 18(2). 262–269. 2 indexed citations
12.
Matsusaka, Satoshi, Wu Zhang, Shu Cao, et al.. (2016). TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy. Molecular Cancer Therapeutics. 15(6). 1405–1411. 11 indexed citations
13.
Sebio, Ana, Sebastian Stintzing, Volker Heinemann, et al.. (2016). A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials. The Pharmacogenomics Journal. 18(1). 43–48. 3 indexed citations
14.
Sunakawa, Yu, Shu Cao, Martin D. Berger, et al.. (2016). Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer. The Pharmacogenomics Journal. 17(6). 528–534. 8 indexed citations
15.
Stintzing, Sebastian, Wu Zhang, Volker Heinemann, et al.. (2015). Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer. Molecular Cancer Therapeutics. 14(10). 2374–2381. 5 indexed citations
16.
Sebio, Ana, Souta Matsusaka, W Zhang, et al.. (2015). Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stages II/III colon cancer. The Pharmacogenomics Journal. 16(4). 312–319. 13 indexed citations
17.
Stintzing, Sebastian, Stefan Stremitzer, Ana Sebio, & Heinz‐Josef Lenz. (2014). Predictive and Prognostic Markers in the Treatment of Metastatic Colorectal Cancer (mCRC). Hematology/Oncology Clinics of North America. 29(1). 43–60. 23 indexed citations
18.
Sebio, Ana, Michaël Kahn, & Heinz‐Josef Lenz. (2014). The potential of targeting Wnt/β-catenin in colon cancer. Expert Opinion on Therapeutic Targets. 18(6). 611–615. 196 indexed citations
19.
Sunakawa, Yu, Stefan Stremitzer, Shu Cao, et al.. (2014). Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer. Annals of Oncology. 26(2). 332–339. 28 indexed citations
20.
Sebio, Ana, Armin Gerger, Satoshi Matsusaka, et al.. (2014). Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer. Pharmacogenetics and Genomics. 25(1). 30–37. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuenong Ouyang Breakdown of academic impact, for papers by Qiang Zuo Breakdown of academic impact, for papers by Xuequan Yao Breakdown of academic impact, for papers by Yufei Jiao Breakdown of academic impact, for papers by Shu Zhao Breakdown of academic impact, for papers by Neyaz Alam Breakdown of academic impact, for papers by Jun Liang Breakdown of academic impact, for papers by Sachin Gopalkrishna Pai Breakdown of academic impact, for papers by Akihiko Miyanaga Breakdown of academic impact, for papers by Song He
Rankless by CCL
2026